Biocon Ltd. (BIOCON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 201791,
    "name": "Biocon",
    "stock_name": "Biocon",
    "full_name": "Biocon Ltd.",
    "name_url": "stocks-analysis/biocon",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "430.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "430.00",
    "mcapval": "69,906.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532523,
    "symbol": "BIOCON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE376G01013",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "24.21 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw",
        "link": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPY1FoQmRoNURaY1puZDF3WmJwb3oxRUFMazBRVWM4Yjh4dEFFQ3daNDY2OFotT1l4YWQxa0JkSnR6S1FLMFFCUmRFSHdDVXFkVjJhcDdhM1FvMWlmVk9OaGRlX2JnR21rMTJXbm9IY2ZZREdfMU5CM085TWJEYVN0MWpNNWxCOHlvZGtTVmJ1MFRwbHQ1bWk2aDczWXgwT0VXaTgtQTgxQ1hDTExLQnp5ZzV6OGpIcEtXVjdMOVZ3WTFjUGtnTnN3WmtBREdKb1dpdWo1Y0dteHBOazZHdk1sLWlR?oc=5",
        "imagepath": "",
        "date": "2026-08-07 06:00:15",
        "description": "US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw  livemint.com..."
      },
      {
        "title": "US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-07 06:00:15",
        "description": "US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw  livemint.com..."
      },
      {
        "title": "Biocon Posts 9% Rise In Q1 Total Income; Biopharma Revenue Up 17%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-06 16:48:35",
        "description": "Biocon Posts 9% Rise In Q1 Total Income; Biopharma Revenue Up 17%  Business Today..."
      },
      {
        "title": "Biocon rises recroding PAT of Rs 141 crore in Q1 FY27",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-06 11:53:19",
        "description": "Biocon rises recroding PAT of Rs 141 crore in Q1 FY27  Business Standard..."
      },
      {
        "title": "Stock Alert: Aurobindo Pharma, PB Fintech, Biocon, Bikaji Foods Intl, JK Lakshmi Cement",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-06 09:14:24",
        "description": "Stock Alert: Aurobindo Pharma, PB Fintech, Biocon, Bikaji Foods Intl, JK Lakshmi Cement  Business Standard..."
      },
      {
        "title": "Biocon consolidated net profit rises 349.36% in the June 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-06 09:09:31",
        "description": "Biocon consolidated net profit rises 349.36% in the June 2026 quarter  Business Standard..."
      },
      {
        "title": "Q1 results today: Aurobindo Pharma, Biocon, PB Fintech, 130 more on Aug 5",
        "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNVm40Q3BBdUZNZm9FRldBcXZUU0VGQ282WWc1QUJjQ2tNNXhVaWlQWWxSSVRySGpHR1h3dlJrMVFYMHdKemNCZThHOTU0eWRLNEt0YUt2czVLekJyb3dldnJIM3hDX3ZBR2RZRVFRX2gyZkpyMkltaTBXblJ0Z3F2MHREQm1pR1g3WFpMT2EwMGtPcU5tVmRYWThweWVvUkRDQ1hXQmJsVmlBbzBYa3J3LWFkdDlsaVYxWmduaEtpd000OThseUlZWTJvSWw5Y2F6ZFhWSFB5clFzbksxLVdjWEJjSnVWQdIB6wFBVV95cUxPS29MaTdYd1NtMkZ6bUZ5YXpCMUxIUnZVcnZoSXRMUWNZU1d1U0RCMmdhTUpRRkxuRnA4YjlQbEFiTy1qbUJoZHBoT2ZySlRzcDV6VW5LTnZQdGNpbEJtY05mOG9mbDNQOEV6UGp1OXhFckRoRDdBMGRSQ3ZGRmZLSjhzT05ZNEhrWnVFa1FiRUNQUzQ2VEg0Mk1fLWw2N0EwamtKRTNhRng0dTRxb0FkRDJ3YzV0V0FucXVQYXg4S21Rb1BaRDBRN21wQUU1WVdnd2lqUGs4b1BpTjlDckw2N1hjUjMxQUwyNEdR?oc=5",
        "imagepath": "",
        "date": "2026-08-05 09:14:13",
        "description": "Q1 results today: Aurobindo Pharma, Biocon, PB Fintech, 130 more on Aug 5  Business Standard..."
      },
      {
        "title": "Biocon launches Yesafili in U.S. market",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-03 09:31:02",
        "description": "Biocon launches Yesafili in U.S. market  Business Standard..."
      },
      {
        "title": "Biocon gets Canadian health regulator\\'s nod for Yesintek autoinjector pen",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-29 12:02:49",
        "description": "Biocon gets Canadian health regulator\\'s nod for Yesintek autoinjector pen  Business Standard..."
      }
    ],
    "total": 30,
    "sid": "201791",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/biocon-201791"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "08-Aug-2026",
      "details": "Voting Results and Scrutinizers report",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper Advertisement",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "07-Aug-2026",
      "details": "Investor Meet",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 03 Jul 26",
          "dt": "2026-07-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19",
          "dt": "2019-06-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw

2026-08-07 06:00:15

US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw livemint.com...

US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw

2026-08-07 06:00:15

US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw livemint.com...

Biocon Posts 9% Rise In Q1 Total Income; Biopharma Revenue Up 17%

2026-08-06 16:48:35

Biocon Posts 9% Rise In Q1 Total Income; Biopharma Revenue Up 17% Business Today...

Biocon rises recroding PAT of Rs 141 crore in Q1 FY27

2026-08-06 11:53:19

Biocon rises recroding PAT of Rs 141 crore in Q1 FY27 Business Standard...

Stock Alert: Aurobindo Pharma, PB Fintech, Biocon, Bikaji Foods Intl, JK Lakshmi Cement

2026-08-06 09:14:24

Stock Alert: Aurobindo Pharma, PB Fintech, Biocon, Bikaji Foods Intl, JK Lakshmi Cement Business Standard...

Biocon consolidated net profit rises 349.36% in the June 2026 quarter

2026-08-06 09:09:31

Biocon consolidated net profit rises 349.36% in the June 2026 quarter Business Standard...

Q1 results today: Aurobindo Pharma, Biocon, PB Fintech, 130 more on Aug 5

2026-08-05 09:14:13

Q1 results today: Aurobindo Pharma, Biocon, PB Fintech, 130 more on Aug 5 Business Standard...

Biocon launches Yesafili in U.S. market

2026-08-03 09:31:02

Biocon launches Yesafili in U.S. market Business Standard...

Biocon gets Canadian health regulator\'s nod for Yesintek autoinjector pen

2026-07-29 12:02:49

Biocon gets Canadian health regulator\'s nod for Yesintek autoinjector pen Business Standard...

View All News